Paper 来了https://www.biorxiv.org/content/10.1101/2021.03.24.436620v1.full.pdf
这里有一篇发表在nature medicine的文章链接~
https://www.nature.com/articles/s41591-021-01377-8
这篇预测了不同疫苗对病毒变种的有效性~
简单来说,就是对原始株有效性高的疫苗(如pfizer, moderna等),在面对变异病毒,虽然有效性下降,仍能维持较高的保护力;但对原始株有效性高不太高的疫苗(如coronaVac), 面对变异病毒时,有效性下降的幅度会比较大。
所以,相对来讲,打mRNA疫苗是比较优的选择~
原文:
“For example, a fivefold lower neutralization titer is predicted to reduce efficacy from 95% to 77% in a high efficacy vaccine, but from 70% to 32% for a vaccine with lower initial efficacy.”
这篇预测了不同疫苗对病毒变种的有效性~
简单来说,就是对原始株有效性高的疫苗(如pfizer, moderna等),在面对变异病毒,虽然有效性下降,仍能维持较高的保护力;但对原始株有效性高不太高的疫苗(如coronaVac), 面对变异病毒时,有效性下降的幅度会比较大。
所以,相对来讲,打mRNA疫苗是比较优的选择~
原文:
“For example, a fivefold lower neutralization titer is predicted to reduce efficacy from 95% to 77% in a high efficacy vaccine, but from 70% to 32% for a vaccine with lower initial efficacy.”